We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Verorab rabies virus vaccine (inactivated) 3.25 IU powder for injection vial with diluent pre-filled syringe with attached needle, Sanofi-Aventis Australia Pty Ltd, CON-1221
Product name
Verorab rabies virus vaccine (inactivated) 3.25 IU powder for injection vial with diluent pre-filled syringe with attached needle
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Batches
X1A061V
Consent start
Consent no.
CON-1221
Duration
The consent is effective from 2 April 2024 until 2 April 2025.
Standard
Subparagraph 8(1)(l)(ii) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
Regarding ‘Instructions for Preparation’ of the product, no statement is included on the label on the container, or the primary pack, or both, that sets out the preparation information itself, and no physical package insert outlining ‘Instructions for Preparation’ will be supplied for the specific batch listed below.
Conditions imposed
1. The product must be supplied with the labels that were previously approved, which contain a QR code on the carton label.
2. Non-compliance with the Therapeutic Goods Order No. 91 is limited to the information detailed in this submission.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines